2019 - ACM Senior Member
His main research concerns Alzheimer's disease, Disease, Genome-wide association study, Genetics and Cognition. His Alzheimer's disease research incorporates themes from Biomarker, Dementia, Gerontology and Age of onset. Robert C. Green interconnects Phenotype, Neuroimaging, Neuroscience and Genetic testing in the investigation of issues within Disease.
The Genetic testing study combines topics in areas such as Bioinformatics, Research design, Genomics, Medical genetics and Exome. His study looks at the intersection of Exome and topics like Personal genomics with DNA sequencing, Penetrance, Personalized medicine, Return of results and Family medicine. He has researched Genetics in several fields, including Hippocampal formation and Apolipoprotein E.
Robert C. Green mostly deals with Disease, Genetic testing, Alzheimer's disease, Internal medicine and Gerontology. The concepts of his Disease study are interwoven with issues in Genotype, Psychiatry and Clinical psychology. His Genetic testing research includes elements of Randomized controlled trial, Family medicine, Personal genomics, Genetic counseling and Risk assessment.
His research integrates issues of Health care, MEDLINE and Genomics in his study of Family medicine. Many of his studies on Personal genomics involve topics that are commonly interrelated, such as Bioinformatics. His biological study deals with issues like Genome-wide association study, which deal with fields such as Neuroscience.
Robert C. Green mainly focuses on Family medicine, Genetic testing, Disease, Randomized controlled trial and Exome sequencing. Robert C. Green has included themes like Health care, Return of results, Pharmacogenetics, Personal genomics and Clinical genomics in his Family medicine study. His Disease study integrates concerns from other disciplines, such as Pharmacogenomics, Genome, Cognition, Neuroimaging and Genotype.
His study focuses on the intersection of Cognition and fields such as Alzheimer's disease with connections in the field of Genome-wide association study. In his study, Bioinformatics is strongly linked to Penetrance, which falls under the umbrella field of Age of onset. His Genomics research incorporates elements of Whole genome sequencing and Medical genetics.
Robert C. Green mainly investigates Genetic testing, Randomized controlled trial, Family medicine, Exome sequencing and Return of results. His Genetic testing research includes themes of Precision medicine, Social psychology, Whole genome sequencing, Genomics and Public health. The various areas that Robert C. Green examines in his Return of results study include Personal genomics and Genomic sequencing.
His study explores the link between Genetics and topics such as Subiculum that cross with problems in Genome-wide association study. His MEDLINE study combines topics from a wide range of disciplines, such as Penetrance, Genome and Exome. Robert C. Green combines subjects such as Bioinformatics and Age of onset with his study of Penetrance.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.
Clifford R. Jack;Matt A. Bernstein;Nick C. Fox;Paul Thompson.
Journal of Magnetic Resonance Imaging (2008)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Carla A Ibrahim-Verbaas;Denise Harold;Adam C Naj.
Nature Genetics (2013)
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Robert C. Green;Robert C. Green;Jonathan S. Berg;Wayne W. Grody;Sarah S. Kalia.
Genetics in Medicine (2013)
Common variants at MS4A4/MS4A6E , CD2AP , CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang.
Nature Genetics (2011)
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Ekaterina Rogaeva;Ekaterina Rogaeva;Yan Meng;Joseph H. Lee;Yongjun Gu;Yongjun Gu.
Nature Genetics (2007)
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Michael W. Weiner;Michael W. Weiner;Dallas P. Veitch;Paul S. Aisen;Laurel A Beckett.
Alzheimers & Dementia (2012)
The impact of plug-in hybrid electric vehicles on distribution networks: A review and outlook
Robert C. Green;Lingfeng Wang;Mansoor Alam.
Renewable & Sustainable Energy Reviews (2011)
Diagnostic Clinical Genome and Exome Sequencing
Leslie G. Biesecker;Robert C. Green.
The New England Journal of Medicine (2014)
Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.
Robert C. Green;Lon S. Schneider;David A. Amato;Andrew P. Beelen.
JAMA (2009)
Depression as a risk factor for Alzheimer disease: the MIRAGE Study.
Robert C. Green;L. Adrienne Cupples;Alex Kurz;Sanford Auerbach.
JAMA Neurology (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Indiana University
University of California, San Francisco
Broad Institute
Boston University
University of Southern California
Indiana University
Mayo Clinic
Boston University
University of Pennsylvania
Columbia University
Google (United States)
Carleton University
Kyoto University
University of Genoa
Aarhus University
Dartmouth College
University of Sannio
University of Virginia
Yonsei University
Scripps Research Institute
University of British Columbia
New York University
Stony Brook University
University of Vienna
New Mexico State University
University of California, Berkeley